COVID-19 is an enormous global challenge that has required an unprecedented level of engagement by stakeholders within pharma, research and policy. While SARS-CoV-2 emerged as a novel virus to which humans had no immunity, infection control measures have been deployed and existing as well as new and emerging technologies are being leveraged to speed the development of new treatments and therapies.
Clarivate partnered with pharma in an international effort to bring life-saving vaccines to market. Joining us in this new episode of Ideas to Innovation are Clarivate experts Danielle Waterman, Senior Quality Specialist, Lynn Yoffee, Publisher BioWorld, and Kevin Yin, Senior Analyst – Medtech Insights, to provide a snapshot of key milestones over the past year and share their perspectives on what is to come. They discuss key medical responses to the pandemic, what the “new normal” looks like and offer analysis and a review of the latest data and insights that can provide a complete view of the healthcare landscape.
“Ideas to Innovation” is a podcast from Clarivate, a global leader in providing solutions to accelerate the lifecycle of innovation, helping customers solve some of the world’s most complex problems. Join Clarivate in conversations with experts and industry leaders to discuss innovation at its core, from science and research to intellectual property and beyond.